RxWare
Wilmington
About RxWare
RxWare is a SaaS company that enables pharmaceutical drug manufacturers to simplify patients' paths to therapy by connecting the siloed patient journey. To improve patient resource utilization and therapy outcomes, the company's Patient Gateway supports a variety of existing patient services and organizations, including ePrescribing systems, Hubs, specialty pharmacies, affordability solutions, system integrators, and nursing vendors. RxWare, which focuses on out-of-the-box connectivity, enables pharmaceutical brands to easily transform complex patient journeys into simple patient experiences. It provides a vendor-neutral digital infrastructure for drug manufacturers to streamline, accelerate, and optimize the entire patient journey. RxWare was founded in 2013.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2020)
- Website: rxware.io
- Phone: 218-392-4373
Industries & Categories
Health Care, Health Diagnostics, Messaging, mHealth, Mobile
Social Profiles
Canonical: https://fsome.com/organization/rxware-74572 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.